Aradigm Corporation Stock Nasdaq
Equities
US0385054004
Biotechnology & Medical Research
Financials (USD)
Sales 2016 | 195K | Sales 2017 | 14.46M | Capitalization | 97.3M |
---|---|---|---|---|---|
Net income 2016 | -32M | Net income 2017 | -10M | EV / Sales 2016 | 73.3 x |
Net cash position 2016 | 9.37M | Net Debt 2017 | 7.91M | EV / Sales 2017 | 7.27 x |
P/E ratio 2016 |
-0.72
x | P/E ratio 2017 |
-9.3
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 60.28% |
1st Jan change | Capi. | |
---|---|---|
-1.74% | 41.35B | |
+42.15% | 40.38B | |
+3.09% | 39.05B | |
-12.11% | 26.67B | |
+1.83% | 24.07B | |
-23.69% | 18.36B | |
-3.81% | 11.68B | |
+21.18% | 11.6B | |
+7.45% | 11.15B |